Latest Trials

Total 45 results

University of Melbourne
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Pneumococcal Vaccination of Fiji Infants

Pneumococcal Infections

Fiji
National Institute of Allergy and Infectious Diseases...

Completed

Streptococcal Infections in Fiji - Prevalence of Group A Streptococcal Pyoderma and Scabies in Infants in Fiji

Streptococcus Group A

Fiji
National Institute of Allergy and Infectious Diseases...

Completed

Prevalence of RHD, Pyoderma and Scabies in Children in Fiji

Streptococcus Group A

Fiji
National Institute of Allergy and Infectious Diseases...

Completed

Incidence of Group A Strep Pharyngitis in School Children in Fiji

Streptococcus Group A

Fiji
Washington University School of Medicine
The Task Force for Global Health; Murdoch Children's Research Institute

Completed

Fiji Integrated Therapy (FIT) - Triple Therapy for Lymphatic Filariasis, Scabies and Soil Transmitted Helminths in Fiji (FIT)

Scabies | Impetigo | Lymphatic Filariases | Soil Transmitted Helminths

Fiji
National Institute of Allergy and Infectious Diseases...

Completed

GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine

Streptococcus Group A

Fiji
Murdoch Childrens Research Institute
Ministry of Health, Fiji

Completed

Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial (PreYIAL)

Bacterial Infections

Fiji
National Institute of Allergy and Infectious Diseases...

Completed

Hospital Based Incidence of Group A Streptococcal Disease in Fiji

Streptococcus Group A

Fiji
Murdoch Childrens Research Institute
Department of Foregin Affairs and Trade, Australia; Ministry of Health, Fiji; The Royal Women Hospital and other collaborators

Completed

Evaluation of Long Term Immunity Following HPV Vaccination

Cervical Cancer | Anogenital Warts

Fiji
University of Oxford
Institut National de la Santé Et de la Recherche Médicale, France; University... and other collaborators

Completed

Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region

Rheumatic Heart Disease | Mitral Stenosis

Fiji, New Caledonia, United Kingdom
Institut National de la Santé Et de la Recherche...
Centers for Disease Control and Prevention; Ministry of Health, Mozambique; War... and other collaborators

Unknown

Infective Endocarditis in Developing Countries, a Prospective, Observational, Multicentre Study (EndoDev)

Infective Endocarditis

Fiji, Lao People's Democratic Republic, Mozambique, Senegal, Uganda
Washington University School of Medicine
Indonesia University; Case Western Reserve University; Ministere de la Sante... and other collaborators

Completed

Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis

Lymphatic Filariases

Fiji, Haiti, India, Indonesia, Papua New Guinea
Mayo Clinic
University of British Columbia

Completed

Implementation of a Web Based Real Time Clinical Decision Support Tool. (CERTAINp)

Sepsis | Shock | Critical Illness | Respiratory Failure | Bleeding

China, India, Croatia, Congo, Fiji, Peru
Eisai Inc.

Completed

A Study Versus E2020 10mg Followed by an Open-label Extension Phase to Explore the Safety of E2020 SR 23 mg in Japanese Subjects With Severe Alzheimer's Type Dementia

Alzheimer's Type Dementia

Japan
Bausch & Lomb Incorporated

Completed

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

Primary Open Angle Glaucoma | Ocular Hypertension

Japan
AstraZeneca

Completed

A Study of Esomeplazole (D961H) in Japanese Paediatric Patients With Reflux Esophagitis, Gastric Ulcer or Duodenal Ulcer

Gastric Ulcer | Duodenal Ulcer | Reflux Esophagitis

Japan
Pfizer

Completed

A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease

Dry Eye Syndromes

Korea, Republic of, Japan
Bayer

Completed

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Hyperphosphatemia

Japan
Novartis Pharmaceuticals

Completed

NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients. (ENA1stepswitch)

Mild to Moderate Alzheimer's Disease

Japan
Hoffmann-La Roche

Completed

A Study Assessing the Safety and Efficacy of Subcutaneous RoActemra/Actemra Alone or in Combination With Non-biologic Antirheumatics in Rhuematoid Arthritis Patients in Latin America With Inadequate Response to Non-biologic Antirheumatic Drugs.

Rheumatoid Arthritis

Brazil, Colombia, Argentina, Dominican Republic, Mexico, Venezuela
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH).

Ocular Hypertension | Glaucoma

Japan
Eisai Co., Ltd.

Completed

Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's Disease

Alzheimer's Type Dementia

Japan
Takeda

Completed

A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Parkinson's Disease

Japan
Takeda

Completed

A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease Participants

Parkinson's Disease

Japan
Takeda

Completed

A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

Parkinson's Disease

Japan
Boehringer Ingelheim

Completed

Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

Parkinson Disease

Japan
Boehringer Ingelheim

Completed

Special Survey on PD Patients With Renal Dysfunction

Parkinson Disease

Japan
AstraZeneca

Completed

Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS). (RATIONAL)

Osteoarthritis (OA) | Rheumatoid Arthritis (RA) | Ankylosing Spondylitis (AS)

Mexico, Vietnam, Malaysia, Argentina, Philippines, Korea, Republic of, Venezuela, Colombia, Russian Federation, Thailand
Eisai Co., Ltd.

Completed

A Study of E2020 in Patients With Dementia With Lewy Bodies (DLB), Followed by a Long-term Extension Phase

Dementia With Lewy Bodies (DLB)

Japan
AbbVie

Completed

Drug Use-Results Survey in Participants Infected With Hepatitis C Virus Genotype 2

Chronic Hepatitis C Virus

Japan
AstraZeneca

Completed

Protocol for the Specified Clinical Experience Investigation on the Single Use of Casodex® Tablet 80 mg (CAMON)

Prostate Cancer

Japan
Novartis Pharmaceuticals

Completed

Long Term Special Drug Use-results Surveillance for Mayzent in SPMS Patients

Secondary Progressive Multiple Sclerosis (SPMS)

Japan
Novartis Pharmaceuticals

Completed

Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Anti-TNFα Agents (REASSURE)

Rheumatoid Arthritis

Colombia, United States, Belgium, Turkey, Thailand, Argentina, Italy, Guatemala, India, Japan, Panama, Hungary, United Kingdom, Mexico, Puerto Rico, Canada
Boehringer Ingelheim

Completed

Special Survey on Parkinson's Disease Patients Treated Long-term Use of Pramipexole

Parkinson Disease

Japan
AbbVie (prior sponsor, Abbott)

Completed

Special Investigation in Patients With Crohn's Disease (All Patients Investigation)

Crohn's Disease

Japan
Janssen Research & Development, LLC

Recruiting

A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) (SunRISe-3)

Bladder Cancer

United States, Belgium, Korea, Republic of, Italy, Taiwan, China, United Kingdom, Germany, France, Argentina, Brazil, Poland, Spain, Czechia, Japan, Netherlands, India, Canada, Mexico, Australia, Portugal
AbbVie

Completed

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Chronic Hepatitis C Virus

Japan
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010) (KEYLYNK-010)

Prostatic Neoplasms

United States, Argentina, Australia, Austria, Brazil, Canada, Chile, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom, New Zealand
Eisai Co., Ltd.

Completed

Quality of Life in New Treatable Therapy as Rabeprazole Option for Refractory Reflux Esophagitis

Refractory Reflux Esophagitis

Japan
Eisai Co., Ltd.

Completed

Investigation of the Safety and Efficacy of Iguratimod in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Japan
Boehringer Ingelheim

Completed

Long-term Observation PMS for Afatinib

Carcinoma, Non-Small-Cell Lung

Japan
Boehringer Ingelheim

Completed

Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Japan
Eisai Co., Ltd.

Completed

Post-marketing Surveillance of Long-term Administration of Donepezil Hydrochloride -Investigation of the Clinical Condition and Safety in Patients With Alzheimer's Disease-

Alzheimer's Disease

Japan
Boehringer Ingelheim

Completed

Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial Fibrillation

Atrial Fibrillation

Japan
AstraZeneca

Terminated

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

Elevated High-sensitivity C-Reactive Protein (hsCRP)

United States, Brazil, Bulgaria, Poland, Russian Federation, South Africa, United Kingdom, Germany, Estonia, Romania, Denmark, Netherlands, Norway, Canada, Mexico, Belgium, Israel, Puerto Rico, Colombia, Argentina, Venezuela, Panama, Urugu... and more

Latest Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations